RCM
BSX icon

Riverhead Capital Management’s Boston Scientific BSX Stock Holding History

Riverhead Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.18M Sell
53,644
-17,416
-25% -$738K 0.08% 312
2019
Q2 		$3.05M Buy
71,060
+36,277
+104% +$1.4M 0.11% 250
2019
Q1 		$1.33M Buy
34,783
+2,109
+6% +$80.5K 0.05% 405
2018
Q4 		$1.16M Buy
32,674
+9,801
+43% +$355K 0.05% 406
2018
Q3 		$881K Sell
22,873
-2,060
-8% -$71.9K 0.03% 526
2018
Q2 		$815K Buy
24,933
+1,295
+5% +$39.1K 0.03% 509
2018
Q1 		$646K Sell
23,638
-7,006
-23% -$190K 0.03% 549
2017
Q4 		$760K Sell
30,644
-8,531
-22% -$235K 0.03% 508
2017
Q3 		$1.14M Sell
39,175
-79,555
-67% -$2.2M 0.05% 370
2017
Q2 		$3.29M Sell
118,730
-64,604
-35% -$1.71M 0.16% 169
2017
Q1 		$4.56M Sell
183,334
-26,499
-13% -$644K 0.25% 113
2016
Q4 		$4.54M Sell
209,833
-9,800
-4% -$214K 0.28% 91
2016
Q3 		$5.23M Buy
219,633
+216,960
+8,117% +$5.18M 0.34% 74
2016
Q2 		$57K Sell
2,673
-1,240,052
-100% -$26.8M ﹤0.01% 1297
2016
Q1 		$23.4M Buy
1,242,725
+313,510
+34% +$5.51M 0.33% 73
2015
Q4 		$17.1M Buy
929,215
+623,370
+204% +$11.2M 0.25% 105
2015
Q3 		$5.02M Buy
305,845
+83,204
+37% +$1.42M 0.08% 302
2015
Q2 		$3.94M Sell
222,641
-9,326
-4% -$167K 0.06% 368
2015
Q1 		$4.12M Sell
231,967
-22,381
-9% -$354K 0.06% 346
2014
Q4 		$3.37M Sell
254,348
-330
-0.1% -$4.22K 0.05% 371
2014
Q3 		$3.01M Buy
254,678
+34,874
+16% +$439K 0.05% 379
2014
Q2 		$2.81M Buy
219,804
+51,639
+31% +$671K 0.05% 372
2014
Q1 		$2.27M Buy
168,165
+14,730
+10% +$193K 0.05% 376
2013
Q4 		$1.84M Buy
153,435
+66,456
+76% +$785K 0.05% 356
2013
Q3 		$1.02M Hold
86,979
– – 0.03% 346
2013
Q2 		$807K Buy
+86,979
New +$738K 0.03% 368

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Riverhead Capital Management's BSX Position: Q3 2019 in Review

Riverhead Capital Management reduced its Boston Scientific (BSX) stake by 25% in Q3 2019, selling an estimated $738K and leaving 53,644 shares worth $2.18M. The position accounts for 0.08% of the portfolio, ranked #312.

Riverhead Capital Management first reported a position in BSX in Q2 2013 and has held it in 26 quarters since. The position peaked at $23.4M in Q1 2016. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Riverhead Capital Management held 53,644 shares of Boston Scientific worth $2.18M as of Q3 2019.
  • Riverhead Capital Management sold 17,416 Boston Scientific shares in Q3 2019, an estimated $738K.
  • Boston Scientific made up 0.08% of Riverhead Capital Management's portfolio in Q3 2019, its #312 holding.
  • Riverhead Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Boston Scientific position peaked at $23.4M in Q1 2016.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.